Vall Vinaithirthan
Biographic Data
| ID | 9650059 |
|---|---|
| NAME | Vall Vinaithirthan |
| GIVEN NAMES | Vall |
| FAMILY NAME | Vinaithirthan |
| SIGNATURE | VINAITHIRTHAN V |
| AFFILIATIONS | University of Colorado Anschutz Medical Campus |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Rapid methods for multi-level dissemination of neutralizing monoclonal antibody treatment for Covid-19 outpatients
Introduction: Throughout the COVID-19 pandemic, there was an urgent need for the rapid and equitable translation of knowledge and effective treatments to reach vulnerable populations in response to the ever-shifting pandemic environment. The approval of neutralizing monoclonal antibodies (mAbs) for treatment of outpatient COVID-19 resulted in a need to rapidly design dissemination strategies to increase awareness and equitable access for communit…
Better Together
Purpose: Burnout refers to feelings of exhaustion and reduced personal efficacy resulting from the workplace and disproportionately affects female medical trainees and physicians compared to both their male and nonphysician counterparts.1,2 Physician burnout begins in training and is linked to increased errors, patient mortality, physician depression, substance abuse, and job turnover.2,3 While physicians have been shown to possess higher levels …
No prominent works on this page.
Better Together
Purpose: Burnout refers to feelings of exhaustion and reduced personal efficacy resulting from the workplace and disproportionately affects female medical trainees and physicians compared to both their male and nonphysician counterparts.1,2 Physician burnout begins in training and is linked to increased errors, patient mortality, physician depression, substance abuse, and job turnover.2,3 While physicians have been shown to possess higher levels …
Rapid methods for multi-level dissemination of neutralizing monoclonal antibody treatment for Covid-19 outpatients
Introduction: Throughout the COVID-19 pandemic, there was an urgent need for the rapid and equitable translation of knowledge and effective treatments to reach vulnerable populations in response to the ever-shifting pandemic environment. The approval of neutralizing monoclonal antibodies (mAbs) for treatment of outpatient COVID-19 resulted in a need to rapidly design dissemination strategies to increase awareness and equitable access for communit…
Medicine (2 works) · 2019-20 coronavirus outbreak (1 work) · Antibody (1 work) · Biology (1 work) · Burnout (1 work) · Clinical Psychology (1 work) · Coaching (1 work) · Compassion fatigue (1 work) · Computer Science (1 work) · Disease (1 work)